Home › Research › Lewy body dementia
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration
Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S et al.. Human molecular genetics, 2006-09-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Null mutations in the progranulin gene (PGRN) were recently reported to cause tau-negative frontotemporal dementia linked to chromosome 17. We assessed the genetic contribution of PGRN mutations in an extended population of patients with frontotemporal lobar degeneration (FTLD) (N=378). Mutations were identified in 10% of the total FTLD population and 23% of patients with a positive family history. This mutation frequency dropped to 5% when analysis was restricted to an unbiased FTLD subpopulation (N=167) derived from patients referred to Alzheimer's Disease Research Centers (ADRC). Among the ADRC patients, PGRN mutations were equally frequent as mutations in the tau gene (MAPT). We identified 23 different pathogenic PGRN mutations, including a total of 21 nonsense, frameshift and splice-site mutations that cause premature termination of the coding sequence and degradation of the mutant RNA by nonsense-mediated decay. We also observed an unusual splice-site mutation in the exon 1 5' splice site, which leads to loss of the Kozac sequence, and a missense mutation in the hydrophobic core of the PGRN signal peptide. Both mutations revealed novel mechanisms that result in loss of functional PGRN. One mutation, c.1477C>T (p.Arg493X), was detected in eight independently ascertained familial FTLD patients who were shown to share a common extended haplotype over the PGRN genomic region. Clinical examination of patients with PGRN mutations revealed highly variable onset ages with language dysfunction as a common presenting symptom. Neuropathological examination showed FTLD with ubiquitin-positive cytoplasmic and intranuclear inclusions in all PGRN mutation carriers.
What this study adds
Evidence grade: Low
The record lists 378 participants. In 378 people with frontotemporal lobar degeneration (FTLD), mutations in the progranulin gene were found in 10%, and in 23% of those with a family history. However, the rate "dropped to 5%" in a less selected group of 167 patients from Alzheimer's research centres, where progranulin mutations were "equally frequent as mutations in the tau gene (MAPT)".
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Gass, J., Cannon, A., Mackenzie, I. R., Boeve, B., Baker, M., Adamson, J., et al. (2006). Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Human molecular genetics. https://doi.org/10.1093/hmg/ddl241
Vancouver
Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Human molecular genetics. 2006. doi:10.1093/hmg/ddl241. PMID: 16950801.
BibTeX
@article{gass2006-16950801,
author = {Gass, J. and Cannon, A. and Mackenzie, I. R. and Boeve, B. and Baker, M. and Adamson, J. and Crook, R. and Melquist, S. and others},
title = {{Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration}},
journal = {Human molecular genetics},
year = {2006},
doi = {10.1093/hmg/ddl241},
pmid = {16950801},
url = {https://doi.org/10.1093/hmg/ddl241}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Both mutations revealed novel mechanisms that result in loss of functional PGRN.
- Clinical examination of patients with PGRN mutations revealed highly variable onset ages with language dysfunction as a common presenting symptom.
Why it matters
In 378 people with frontotemporal lobar degeneration (FTLD), mutations in the progranulin gene were found in 10%, and in 23% of those with a family history. However, the rate "dropped to 5%" in a less selected group of 167 patients from Alzheimer's research centres, where progranulin mutations were "equally frequent as mutations in the tau gene (MAPT)". All 23 mutations described lead to loss of working progranulin. Carriers often first showed language problems, and their age at onset varied widely. This is a genetic study of FTLD, not Alzheimer's disease, and it tests no treatment.
Study details
- Participants378
- Evidence strengthLow
How this study scored 59/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Human molecular genetics) |
| Journal's citation record | 3 / 4 | Human Molecular Genetics: journal h-index 356 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2006 — older than 20 years, still counted |
| Sample size | 2 / 4 | 378 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 581 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 26.4 citations a year over 22 year(s) since 2006 |
| Impact for its field and year | 5 / 6 | Cited 32.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 38 other studies in this library |
| Still being cited | 3 / 4 | Cited 60 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Rosa Rademakers: h-index 119 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Mayo Clinic: institution h-index 1,606 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 16950801) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.
Later studies that cite this one
38 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Lewy body dementia from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.